Rinvatercept

N/A

Report date: 2026/03/11 20:02:12

Base Information

Drug NameRinvatercept
Drug Alias NameKER-065RKER-065
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionActivin inhibitorsGrowth/differentiation factor 8 inhibitors
TargetsActivinsGrowth/differentiation factor 8
Therapy Area/IndicationsObesityNeuromuscular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKeros Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKeros Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsObesityNeuromuscular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A